Important progress in the Spiegel Research Group

February 10, 2010

The Spiegel Research Group has recently made important strides in their work involving antibody-recruiting small molecules that target HIV and prostate cancer.  These molecules function by redirecting antibodies present in the human bloodstream to proteins expressed on the surface of human pathogens, and represent novel and potentially general strategies for disease treatment.  These studies were recently published in JACS, and have been highlighted in various venues, including ACS Chemical BiologyFaculty of 1000 BiologyPopular ScienceR&D Magazinee! Science NewsScience DailyGenetic Engineering & Biotechnology News, & ACS Noteworthy Chemistry.